T1	Participants 369 418	subjects with symptomatic moderate to severe COPD
T2	Participants 510 715	Subjects 40 years or older with cigarette smoking history ≥10 pack-years and with the diagnosis of COPD and post-bronchodilator FEV(1) ≥40 to ≤ 80% of predicted normal and FEV(1)/FVC of ≤0.70 were enrolled
T3	Participants 1599 1617	subjects with COPD
